153 related articles for article (PubMed ID: 15985454)
1. Corticosteroid-regulated genes in rat kidney: mining time series array data.
Almon RR; Lai W; DuBois DC; Jusko WJ
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E870-82. PubMed ID: 15985454
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic responses of rat liver to methylprednisolone: an approach to mining a rich microarray time series.
Almon RR; Dubois DC; Jin JY; Jusko WJ
AAPS J; 2005 Aug; 7(1):E156-94. PubMed ID: 16146338
[TBL] [Abstract][Full Text] [Related]
3. A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens.
Almon RR; DuBois DC; Jusko WJ
Endocrinology; 2007 May; 148(5):2209-25. PubMed ID: 17303664
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens.
Almon RR; DuBois DC; Yao Z; Hoffman EP; Ghimbovschi S; Jusko WJ
Physiol Genomics; 2007 Aug; 30(3):282-99. PubMed ID: 17473217
[TBL] [Abstract][Full Text] [Related]
5. Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle.
Almon RR; Dubois DC; Jin JY; Jusko WJ
J Endocrinol; 2005 Jan; 184(1):219-32. PubMed ID: 15642798
[TBL] [Abstract][Full Text] [Related]
6. Gene arrays and temporal patterns of drug response: corticosteroid effects on rat liver.
Almon RR; DuBois DC; Pearson KE; Stephan DA; Jusko WJ
Funct Integr Genomics; 2003 Dec; 3(4):171-9. PubMed ID: 12928814
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing.
Yao Z; Hoffman EP; Ghimbovschi S; Dubois DC; Almon RR; Jusko WJ
Mol Pharm; 2008; 5(2):328-39. PubMed ID: 18271548
[TBL] [Abstract][Full Text] [Related]
8. The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series.
Almon RR; DuBois DC; Piel WH; Jusko WJ
Pharmacogenomics; 2004 Jul; 5(5):525-52. PubMed ID: 15212590
[TBL] [Abstract][Full Text] [Related]
9. Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays.
Jin JY; Almon RR; DuBois DC; Jusko WJ
J Pharmacol Exp Ther; 2003 Oct; 307(1):93-109. PubMed ID: 12808002
[TBL] [Abstract][Full Text] [Related]
10. Bayesian models and meta analysis for multiple tissue gene expression data following corticosteroid administration.
Liang Y; Kelemen A
BMC Bioinformatics; 2008 Aug; 9():354. PubMed ID: 18755028
[TBL] [Abstract][Full Text] [Related]
11. Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle.
Almon RR; Yang E; Lai W; Androulakis IP; Ghimbovschi S; Hoffman EP; Jusko WJ; Dubois DC
Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1031-47. PubMed ID: 18667713
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis.
Burton GR; Nagarajan R; Peterson CA; McGehee RE
Gene; 2004 Mar; 329():167-85. PubMed ID: 15033539
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis.
Almon RR; DuBois DC; Brandenburg EH; Shi W; Zhang S; Straubinger RM; Jusko WJ
J Pharmacokinet Pharmacodyn; 2002 Apr; 29(2):103-29. PubMed ID: 12361239
[TBL] [Abstract][Full Text] [Related]
14. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats.
Davidson ME; Kerepesi LA; Soto A; Chan VT
Arch Toxicol; 2009 Aug; 83(8):747-62. PubMed ID: 19212759
[TBL] [Abstract][Full Text] [Related]
15. Use of gene chip technology for the characterisation of the regulation of renal transport processes and of nephrotoxicity in rats.
Fleck C; Sutter L; Appenroth D; Koch B; Meinhold T; Pitack M; Gasser R
Exp Toxicol Pathol; 2003 Jun; 54(5-6):401-10. PubMed ID: 12877352
[TBL] [Abstract][Full Text] [Related]
16. Application of scaling factors in simultaneous modeling of microarray data from diverse chips.
Yao Z; Zhao B; Hoffman EP; Ghimbovschi S; DuBois DC; Almon RR; Jusko WJ
Pharm Res; 2007 Apr; 24(4):643-9. PubMed ID: 17318415
[TBL] [Abstract][Full Text] [Related]
17. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
18. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements.
Carter SL; Eklund AC; Mecham BH; Kohane IS; Szallasi Z
BMC Bioinformatics; 2005 Apr; 6():107. PubMed ID: 15850491
[TBL] [Abstract][Full Text] [Related]
19. In vivo multi-tissue corticosteroid microarray time series available online at Public Expression Profile Resource (PEPR).
Almon RR; Chen J; Snyder G; DuBois DC; Jusko WJ; Hoffman EP
Pharmacogenomics; 2003 Nov; 4(6):791-9. PubMed ID: 14596642
[TBL] [Abstract][Full Text] [Related]
20. Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius.
Gayan-Ramirez G; Vanderhoydonc F; Verhoeven G; Decramer M
Am J Respir Crit Care Med; 1999 Jan; 159(1):283-9. PubMed ID: 9872851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
